Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06453083 · ClinicalTrials.gov registry record · Early Phase 1

Medrol Dose Packs for Post-Operative Pain Control

A Early Phase 1 study of Pain, sponsored by University of Utah.

Completed
Registry status
Early Phase 1
Development phase
57
Enrollment target
1
Study location

NCT06453083 is a Early Phase 1 study of Pain that has completed, run by University of Utah. The registered enrollment target is 57 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06453083, a Early Phase 1 study of Pain, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Early Phase 1
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Medrol

Study Locations (1)

Utah

  • University of Utah Orthopaedic Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2023-01-13
Est. Completion 2024-12-17
Phase Early Phase 1

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT06453083

The ClinicalTrials.gov registry entry for NCT06453083 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06453083 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT06453083 about?

NCT06453083 is a clinical study titled "Medrol Dose Packs for Post-Operative Pain Control". The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.

What is the current status of trial NCT06453083?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 57 participants. The study started on 2023-01-13. Estimated completion is 2024-12-17.

What conditions does trial NCT06453083 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT06453083?

The interventions under investigation include: Placebo (DRUG), Medrol (DRUG).

Who is sponsoring clinical trial NCT06453083?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06453083 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.